Latest news

Thumbnail image for Amryt in-licenses novel gene therapy platform from UCD

Amryt in-licenses novel gene therapy platform from UCD

UK biotech Amryt has secured itself access to a novel gene therapy platform that could give rise to a new treatment option for patients with Epidermolysis bullosa (EB), a group of rare inherited skin disorders that cause the skin to become very fragile.

16th March 2018

Thumbnail image for Alexion gears up to file new blood disorder drug

Alexion gears up to file new blood disorder drug

Alexion is gearing up to file its experimental therapy for paroxysmal nocturnal hemoglobinuria (PNH) with regulators on both sides of the Altantic following the success of a late-stage clinical trial.

16th March 2018

Thumbnail image for NICE endorses Keytruda for bladder cancer

NICE endorses Keytruda for bladder cancer

MSD’s Keytruda is the first and only immunotherapy to be recommended for NHS use to treat urothelial carcinoma patients, when prior platinum-containing chemotherapy fails.

16th March 2018

Thumbnail image for Chancellor criticised for lack of action on NHS

Chancellor criticised for lack of action on NHS

Chancellor Philip Hammond boosted growth projections and forecast falling inflation for the UK in his Spring Statement, but health care leaders lamented his lack of action on addressing the NHS crisis.

14th March 2018

Previous  --   4 5 6 7 8 9 10 11 12 13   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download